Medivir AB (publ) MVIR-B.ST
Trading inactive
MVIR-B.ST
Medivir AB (publ) PROMO.ST
Promore Pharma AB (publ) ABLI.ST
Abliva AB (publ) ISR.ST
ISR Immune System Regulation Holding AB (publ) COMBI.ST
CombiGene AB (publ) KAN.ST
Kancera AB (publ) LIPI.ST
Lipidor AB (publ) SCOL.ST
Scandion Oncology A/S PHARM.ST
Pharmiva AB (publ) AMNI.ST
Amniotics AB (publ)
Medivir AB (publ) PROMO.ST
Promore Pharma AB (publ) ABLI.ST
Abliva AB (publ) ISR.ST
ISR Immune System Regulation Holding AB (publ) COMBI.ST
CombiGene AB (publ) KAN.ST
Kancera AB (publ) LIPI.ST
Lipidor AB (publ) SCOL.ST
Scandion Oncology A/S PHARM.ST
Pharmiva AB (publ) AMNI.ST
Amniotics AB (publ)
Performance
| Periode | MVIR-B.ST | PROMO.ST | ABLI.ST | ISR.ST | COMBI.ST | KAN.ST | LIPI.ST | SCOL.ST | PHARM.ST | AMNI.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -24.71 % | -13.73 % | 193.26 % | -76.67 % | 2.07 % | -75.81 % | 18.78 % | -92.04 % | -42.15 % | 42.11 % |
| YTD | -25.95 % | 8.91 % | 4.23 % | 0.00 % | 8.33 % | -72.45 % | -11.16 % | -94.46 % | -66.16 % | -34.15 % |
| 1Y | -5.62 % | -86.78 % | 177.50 % | -76.78 % | -16.55 % | -83.65 % | 54.12 % | -97.44 % | -66.67 % | -69.66 % |
| 3Y | -39.77 % | -95.80 % | -4.52 % | -71.89 % | -70.73 % | -87.45 % | -96.36 % | -99.94 % | -94.67 % | -99.96 % |
| 5Y | -81.30 % | -99.05 % | -44.43 % | -86.27 % | -84.96 % | -98.98 % | -98.79 % | -99.99 % | -94.67 % | -99.96 % |
| 10Y | -89.65 % | -99.08 % | -98.98 % | -86.98 % | -98.83 % | -99.25 % | -96.81 % | -99.95 % | -94.67 % | -99.96 % |
| Depuis le début | -91.07 % | -99.08 % | -89.73 % | -86.98 % | -98.58 % | -99.27 % | -96.81 % | -99.95 % | -94.67 % | -99.96 % |